Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Using Modular Systems in Solid-Dosage Manufacturing

April 15, 2014

The authors describe how modular systems can be applied to continuous solid-dosage and nutraceutical manufacturing.

Advances in Hot-Melt Extrusion Manufacturing

April 15, 2014

Charlie Martin, Leistritz Extrusion, describes hot-melt extrusion manufacturing processes and advances.

Obtaining User-Defined Particle Size Distribution Using Dry Granulation

April 15, 2014

The author examines the effect of compaction force, gap width, and sieve setup on granule size.

A Quality-by-Design Approach to Optimize In-Process Curing of EUDRAGIT NM 30 D

April 15, 2014

A study investigated the influence and correlation of critical process parameters for the optimization of in-process curing.

Selection of Excipients in Generic Formulations

April 15, 2014

The selection of excipients is important in generic formulations due to the impact it has on the risk and performance of generic drugs.

FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines

April 10, 2014

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Dalton Pharma Completes Aseptic Filling Capabilities Expansion

April 07, 2014

Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

April 02, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Increased Efficiency Key to Competitiveness in Downstream Bioprocessing

April 02, 2014

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.

New Softgel Technologies

April 01, 2014

Catalent Pharma Solutions recently launched several new softgel product developments, all of which solve a delivery problem, while offering IP advantages to drug manufacturers.